Star Homes Project 2 (SHP2)
Primary Purpose
Malaria, Respiratory Tract Infection Acute, Diarrhoea;Acute
Status
Recruiting
Phase
Not Applicable
Locations
Tanzania
Study Type
Interventional
Intervention
Star Homes
Traditional African houses
Sponsored by
About this trial
This is an interventional prevention trial for Malaria focused on measuring Healthy houses, Tanzania
Eligibility Criteria
Inclusion Criteria
Main study
- Children, aged under 13 years old, male or female
- Residing in a study village for at least 3 years
- Parents/guardian is willing and able to give written informed consent for the child to participate in the baseline and end-of study evaluation and the surveillance for malaria, respiratory tract infection and diarrhoeal disease.
- Additionally, children 10, 11, and 12 years of age provide assent to participate.
Ancillary studies
- Head of a household or other family member of a household that is taking part in the main study
- 18 years and above
- Consent to take part in the main study
- Residing and live in the village for 3 years or more
- Live in the intervention or comparison houses or a trusted community member (community leaders, medical officer and community health worker)
Exclusion criteria
Main study
- Any participant who refuses, or in the case of children whose parents/guardian refuses, to participate in the study.
- Any child who is between 10 and 12 years who refuses to provide assent
- If the family plans for moving to other village during the study period
- Parents/guardians have mental health problems
Ancillary studies
- Under 18 years
- Not provide consent
- Not living in the study village for 3 years or more
Sites / Locations
- CSK Research SolutionsRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
Arm 1
Arm 2
Arm Description
Households living in novel-design houses.
Households living in traditional African houses.
Outcomes
Primary Outcome Measures
Incidence of malaria in children under 13 years of age.
The incidence per year of malaria in children under 13 years old.
Incidence of respiratory tract disease in children under 13 years of age.
The incidence per year of respiratory tract disease in children under 13 years old.
Incidence of diarrhoeal disease in children under 13 years of age.
The incidence per year of diarrhoeal disease in children under 13 years old.
Secondary Outcome Measures
Mean number of female An. gambiae s.l.
Mean number of female An. gambiae s.l./light trap/night
Mean number of flies
Mean number of flies/sticky trap/week in kitchens of the houses
Entomological inoculation rate of malaria vectors.
Compare entomological inoculation rate of mosquito inside novel and traditional rural houses.
Children requiring hospital admission
Compare hospitalization rate of children under 13 years living inside novel and traditional rural houses.
Major respiratory pathogens
From children requiring hospital admission, the most frequently detected respiratory tract pathogens will be assessed through blood culture.
Major enteric pathogens
From children requiring hospital admission, the most frequently detected enteric pathogens will be assessed through rotavirus ELISA testing and bacterial culture of stool specimens.
Prevalence of malaria parasitaemia among children living in novel design houses and traditional homes.
Prevalence will be assessed from a cross-sectional surveys of children, based on dried blood smears will be collected for quantitative polymerase chain reaction once per quarter.
Mean changes in weight
Weight in kilograms of children under 13 years of age recorded at baseline, annually and at end of the study.
Mean changes in height
Height in meters of children under 13 years of age recorded at baseline, annually and at end of the study.
Mean changes in body mass index (BMI)
BMI in Kg/m2 in meters of children under 13 years of age recorded at baseline, annually and at end of the study.
Mean changes in mid-upper arm circumference
Mid-upper arm circumference in millimeters of children under 13 years of age recorded at baseline, annually and at end of the study.
Disease severity
A subgroup analysis of children requiring hospital consultation and children requiring hospitalization.
Indoor temperature
Temperature will be measured using data loggers.
Humidity
Humidity will be measured using data loggers.
Carbon dioxide (CO2)
Carbon dioxide (CO2) will be measured using data loggers.
Particulate matter 2.5 (PM2.5) particle pollution
PM2.5 particle pollution will be measured using data loggers.
Acceptability of the novel design houses.
The acceptability will be measured through a mixed method: 1) quantitative method i.e. closed ended questions with a pre-determined set of choices 2) qualitative method i.e. open ended questions through focused group discussions and in-depth interviews.
Bednet use
Assessed by asking residents and in children with less than 5 years old in traditional and novel design homes regarding the use of insecticide treated bednets.
Life-cycle analysis
This is the cost of illness averted by living in a novel-designed home against a background of complete coverage with insecticide-treated nets. The analysis will include cost comparison (construction and maintenance of novel and control houses) and market analysis.
Durability
Yearly inspections of houses (control and intervention). Maintenance of structural problems on demand.
Full Information
NCT ID
NCT04529434
First Posted
August 6, 2020
Last Updated
June 27, 2022
Sponsor
University of Oxford
Collaborators
Mahidol Oxford Tropical Medicine Research Unit, CSK Research Solutions
1. Study Identification
Unique Protocol Identification Number
NCT04529434
Brief Title
Star Homes Project 2
Acronym
SHP2
Official Title
Star Homes - Better Health Through Better Housing: Phase 2 House Evaluation
Study Type
Interventional
2. Study Status
Record Verification Date
June 2022
Overall Recruitment Status
Recruiting
Study Start Date
January 4, 2022 (Actual)
Primary Completion Date
January 3, 2025 (Anticipated)
Study Completion Date
December 31, 2025 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Oxford
Collaborators
Mahidol Oxford Tropical Medicine Research Unit, CSK Research Solutions
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Malaria, pneumonia and diarrhoea causes a lot of illness in children in Tanzania and the study want to find better ways of protecting people against these diseases and want to find out if the type of house design can affect the general health of children living in the house.
Detailed Description
The study hypothesis is that healthy houses will reduce the incidence of malaria, respiratory diseases and diarrhoeal diseases in children compared with traditional houses. And healthy houses are also likely to reduce the incidence of all-cause morbidity incidence, disease severity, improve growth and well-being. The primary endpoints will be assessed in children under 13 years of age through weekly household visits for three years. All homes will have access to basic vector control, such as insecticide treated nets (ITNs). Access to early diagnosis and appropriate malaria treatment will be assured. Approximately 2,750 Tanzanians living in 550 houses in Mtwara region, of which 110 are new design houses (Star Homes) and the remaining 440 traditional African houses will be participating in this study. 330 children living in the novel design houses and 1320 children in traditional homes will be followed for three years for the assessment of malaria, respiratory tract infections and diarrhoea. Mosquito density will be assessed from all 550 houses where tent/light trap will be used for mosquito catch at night in all study houses. Acceptance of the novel designed houses will be assessed using mixed methods. Acceptability surveys will be conducted with 550 household heads concurrently with in-depth interviews with 30 purposively selected heads of the households in the intervention arm. Ten focus group discussions will be conducted each comprising 10 heads of households making it to be 100 heads of households.
Funder: Hanako Foundation, Singapore
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malaria, Respiratory Tract Infection Acute, Diarrhoea;Acute
Keywords
Healthy houses, Tanzania
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This is an open-label household randomised controlled trial that will compare the 110 novel-design houses with 440 traditional African homes.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
2750 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Arm 1
Arm Type
Experimental
Arm Description
Households living in novel-design houses.
Arm Title
Arm 2
Arm Type
Other
Arm Description
Households living in traditional African houses.
Intervention Type
Other
Intervention Name(s)
Star Homes
Intervention Description
110 identical novel-designed houses, known as Star Homes, include the critical structural components e.g. building orientated to provide optimal shading throughout the day, light-weight & durable roof, facade and openings screened from insects to reduce insect entry while assuring airflow, an outdoor fly-proof latrine, and solar power providing electric light at night etc.
Intervention Type
Other
Intervention Name(s)
Traditional African houses
Intervention Description
A traditional mud house: with wattle and daub walls, a thatched roof, and no electricity or piped water supply.
Primary Outcome Measure Information:
Title
Incidence of malaria in children under 13 years of age.
Description
The incidence per year of malaria in children under 13 years old.
Time Frame
Approximately 3 years
Title
Incidence of respiratory tract disease in children under 13 years of age.
Description
The incidence per year of respiratory tract disease in children under 13 years old.
Time Frame
Approximately 3 years
Title
Incidence of diarrhoeal disease in children under 13 years of age.
Description
The incidence per year of diarrhoeal disease in children under 13 years old.
Time Frame
Approximately 3 years
Secondary Outcome Measure Information:
Title
Mean number of female An. gambiae s.l.
Description
Mean number of female An. gambiae s.l./light trap/night
Time Frame
Approximately 3 years
Title
Mean number of flies
Description
Mean number of flies/sticky trap/week in kitchens of the houses
Time Frame
Approximately 3 years
Title
Entomological inoculation rate of malaria vectors.
Description
Compare entomological inoculation rate of mosquito inside novel and traditional rural houses.
Time Frame
Approximately 3 years
Title
Children requiring hospital admission
Description
Compare hospitalization rate of children under 13 years living inside novel and traditional rural houses.
Time Frame
Approximately 3 years
Title
Major respiratory pathogens
Description
From children requiring hospital admission, the most frequently detected respiratory tract pathogens will be assessed through blood culture.
Time Frame
Approximately 3 years
Title
Major enteric pathogens
Description
From children requiring hospital admission, the most frequently detected enteric pathogens will be assessed through rotavirus ELISA testing and bacterial culture of stool specimens.
Time Frame
Approximately 3 years
Title
Prevalence of malaria parasitaemia among children living in novel design houses and traditional homes.
Description
Prevalence will be assessed from a cross-sectional surveys of children, based on dried blood smears will be collected for quantitative polymerase chain reaction once per quarter.
Time Frame
Approximately 3 years
Title
Mean changes in weight
Description
Weight in kilograms of children under 13 years of age recorded at baseline, annually and at end of the study.
Time Frame
Approximately 3 years
Title
Mean changes in height
Description
Height in meters of children under 13 years of age recorded at baseline, annually and at end of the study.
Time Frame
Approximately 3 years
Title
Mean changes in body mass index (BMI)
Description
BMI in Kg/m2 in meters of children under 13 years of age recorded at baseline, annually and at end of the study.
Time Frame
Approximately 3 years
Title
Mean changes in mid-upper arm circumference
Description
Mid-upper arm circumference in millimeters of children under 13 years of age recorded at baseline, annually and at end of the study.
Time Frame
Approximately 3 years
Title
Disease severity
Description
A subgroup analysis of children requiring hospital consultation and children requiring hospitalization.
Time Frame
Approximately 3 years
Title
Indoor temperature
Description
Temperature will be measured using data loggers.
Time Frame
Approximately 2 years
Title
Humidity
Description
Humidity will be measured using data loggers.
Time Frame
Approximately 2 years
Title
Carbon dioxide (CO2)
Description
Carbon dioxide (CO2) will be measured using data loggers.
Time Frame
Approximately 2 years
Title
Particulate matter 2.5 (PM2.5) particle pollution
Description
PM2.5 particle pollution will be measured using data loggers.
Time Frame
Approximately 2 years
Title
Acceptability of the novel design houses.
Description
The acceptability will be measured through a mixed method: 1) quantitative method i.e. closed ended questions with a pre-determined set of choices 2) qualitative method i.e. open ended questions through focused group discussions and in-depth interviews.
Time Frame
Interviews at 6 months after moving in, 1 year and at the end of the study
Title
Bednet use
Description
Assessed by asking residents and in children with less than 5 years old in traditional and novel design homes regarding the use of insecticide treated bednets.
Time Frame
Annually (for three years)
Title
Life-cycle analysis
Description
This is the cost of illness averted by living in a novel-designed home against a background of complete coverage with insecticide-treated nets. The analysis will include cost comparison (construction and maintenance of novel and control houses) and market analysis.
Time Frame
Over 36 months period starting from moving in date.
Title
Durability
Description
Yearly inspections of houses (control and intervention). Maintenance of structural problems on demand.
Time Frame
End of year 1, 2 and 3.
10. Eligibility
Sex
All
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria
Main study
Children, aged under 13 years old, male or female
Residing in a study village for at least 3 years
Parents/guardian is willing and able to give written informed consent for the child to participate in the baseline and end-of study evaluation and the surveillance for malaria, respiratory tract infection and diarrhoeal disease.
Additionally, children 10, 11, and 12 years of age provide assent to participate.
Ancillary studies
Head of a household or other family member of a household that is taking part in the main study
18 years and above
Consent to take part in the main study
Residing and live in the village for 3 years or more
Live in the intervention or comparison houses or a trusted community member (community leaders, medical officer and community health worker)
Exclusion criteria
Main study
Any participant who refuses, or in the case of children whose parents/guardian refuses, to participate in the study.
Any child who is between 10 and 12 years who refuses to provide assent
If the family plans for moving to other village during the study period
Parents/guardians have mental health problems
Ancillary studies
Under 18 years
Not provide consent
Not living in the study village for 3 years or more
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lorenz von Seidlein, Ass.Prof.
Phone
66 9 2648-6322
Email
Lorenz@tropmedres.ac
First Name & Middle Initial & Last Name or Official Title & Degree
Salum Mshamu, Dr.
Email
salum.mshamu@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lorenz von Seidlein, Ass.Prof.
Organizational Affiliation
Mahidol Oxford Tropical Medicine Research Unit
Official's Role
Principal Investigator
Facility Information:
Facility Name
CSK Research Solutions
City
Dar Es Salaam
State/Province
Mtwara
Country
Tanzania
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Lorenz von Seidlein, Assoc. Prof
Phone
66 9 2648-6322
Email
Lorenz@tropmedres.ac
First Name & Middle Initial & Last Name & Degree
Salum Mshamu, Dr.
Email
salum.mshamu@gmail.com
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Data collected for this study will be under the custodianship of MORU. With participant's consent, data from this study may be shared in a de-identified form with other groups or researchers in accordance with the MORU Data Sharing Policy.
IPD Sharing Time Frame
After completion of trial activities and reporting
IPD Sharing Access Criteria
MORU Data Sharing Policy. (http://www.tropmedres.ac/data-sharing-policy)
Citations:
PubMed Identifier
35725486
Citation
Mshamu S, Mmbando A, Meta J, Bradley J, Bojstrup TC, Day NPJ, Mukaka M, Okumu F, Olotu A, Pell C, Deen J, Knudsen J, Lindsay SW, von Seidlein L. Assessing the impact of a novel house design on the incidence of malaria in children in rural Africa: study protocol for a household-cluster randomized controlled superiority trial. Trials. 2022 Jun 20;23(1):519. doi: 10.1186/s13063-022-06461-z. Erratum In: Trials. 2022 Jul 7;23(1):550.
Results Reference
derived
Learn more about this trial
Star Homes Project 2
We'll reach out to this number within 24 hrs